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Advancing age is the top risk factor for the development of neurodegenerative disorders,
including Alzheimer’s disease (AD). However, the contribution of aging processes to
AD etiology remains unclear. Emerging evidence shows that reduced brain metabolic
and vascular functions occur decades before the onset of cognitive impairments,
and these reductions are highly associated with low-grade, chronic inflammation
developed in the brain over time. Interestingly, recent findings suggest that the gut
microbiota may also play a critical role in modulating immune responses in the brain
via the brain-gut axis. In this study, our goal was to identify associations between
deleterious changes in brain metabolism, cerebral blood flow (CBF), gut microbiome
and cognition in aging, and potential implications for AD development. We conducted
our study with a group of young mice (5–6 months of age) and compared those
to old mice (18–20 months of age) by utilizing metabolic profiling, neuroimaging, gut
microbiome analysis, behavioral assessments and biochemical assays. We found that
compared to young mice, old mice had significantly increased levels of numerous
amino acids and fatty acids that are highly associated with inflammation and AD
biomarkers. In the gut microbiome analyses, we found that old mice had increased
Firmicutes/Bacteroidetes ratio and alpha diversity. We also found impaired blood-
brain barrier (BBB) function and reduced CBF as well as compromised learning and
memory and increased anxiety, clinical symptoms often seen in AD patients, in old
mice. Our study suggests that the aging process involves deleterious changes in
brain metabolic, vascular and cognitive functions, and gut microbiome structure and
diversity, all which may lead to inflammation and thus increase the risk for AD. Future
studies conducting comprehensive and integrative characterization of brain aging,
including crosstalk with peripheral systems and factors, will be necessary to define the
mechanisms underlying the shift from normal aging to pathological processes in the
etiology of AD.
Keywords: aging, MRI, brain metabolism, neurovascular function, gut microbiome, cognition, anxiety, Alzheimer’s
disease
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INTRODUCTION
Advancing age increases the risk factor for developing
dementia, with imaging and biomarker data suggesting that
the pathophysiological processes of Alzheimer’s disease (AD)
begin more than a decade prior to the diagnosis of dementia
(Reiman et al., 2004; Reitz et al., 2011; Bangen et al., 2013).
However, how aging processes contribute to AD etiology still
remains unclear. Bioenergetic imbalance over time has been
considered as one of the primary causes for these chronic
disorders (Wallace, 2011). In the central nervous system, brain
energy supply declines with age (Petit-Taboué et al., 1998).
Failure to maintain brain metabolism causes dysfunctional
cellular energy status and nucleotide biosynthesis (Ivanisevic
et al., 2016), leading to cognitive impairment and brain volume
atrophy (Everson-Rose and Ryan, 2015). In addition, this
energetic imbalance leads to neuroinflammation accompanied
by reduced neuronal activity and increased glial activation
(Boumezbeur et al., 2010; Lynch et al., 2010; O’Neill et al.,
2016; Ron-Harel et al., 2016). Glial over-activation can cause
release of inducible nitric oxide synthase (iNOS), which can
result in inflammation and sepsis (Wong et al., 1996). Chronic
neuroinflammation can further lead to retention of amyloid
beta (Aβ) plaques and tau tangles as seen in AD, and ultimately,
memory loss and dementia (Wyss-Coray and Rogers, 2012).
Emerging evidence shows the metabolic imbalance and
inflammatory responses may not only originate in the brain
per se, but also from gut microbiota (Kau et al., 2011). The gut
microbiota is the community of microorganisms in the intestines
that contains over 1000 different bacterial species, categorized
into four primary phyla: Firmicutes, Bacteroidetes, Actinobacteria
and Proteobacteria (Verbeke et al., 2014). A number of studies
have demonstrated that the gut microbiota changes with age
(Biagi et al., 2010; Claesson et al., 2011; Langille et al., 2014).
In particular, an increased Firmicutes/Bacteroidetes (F/B) ratio
is associated with increased inflammation and excess energy
harvest from food in obese patients (Verdam et al., 2013).
Increased F/B ratio is associated with the weakening of the
epithelial tight junctions, allowing proinflammatory cytokines
produced by pathogenic bacteria transfer to the brain from
the blood stream or vagus nerve (Braniste et al., 2014; Al-
Asmakh and Hedin, 2015). Inflammation due to leaky gut
syndrome has also been shown to increase the risk for anxiety
and depression (Dinan and Cryan, 2013), which can exacerbate
learning and memory performance (Foster, 2016; Sharon et al.,
2016).
Leaky gut syndrome also leads to neurovascular defects,
evident by increased blood-brain barrier (BBB) permeability
(Braniste et al., 2014). The reduction of BBB transporters may
lead to impaired clearance of Aβ (Zlokovic, 2011; Bell et al.,
2012), enhancing the risk of dementia like symptoms (Erickson
and Banks, 2013). Impaired BBB function is also linked with
reduced cerebral blood flow (CBF; Bell et al., 2012). Indeed,
reductions in CBF with age have been known for years (Melamed
et al., 1980). These neurovascular risks are highly associated with
accelerated decline in language ability, verbal memory, attention
and visuospatial abilities, and increased anxiety and depression
in aging (Gur et al., 1987; Ebmeier et al., 1997; Zlokovic, 2011;
Bangen et al., 2013; Park and Moghaddam, 2017).
Collectively, the cognitive aging and risk for AD may be
driven by deleterious changes of brain physiology originated
from the central nervous system as well as the peripheral systems.
Nonetheless, the associations between brain metabolism,
perfusion, cognition and gut microbiome remain largely
unknown. In this study, our objective was to examine the effects
of aging on the brain and the gut in young and old mice and how
these effects collectively alter neurological function. To achieve
this, we used metabolomics for brain metabolite assessment,
16s ribosomal RNA (rRNA) gene amplicon sequencing to
analyze the gut microbiome, neuroimaging to examine brain
vascular functions, and behavioral testing to determine memory
and anxiety. We hypothesized that age-related deleterious
changes would be exhibited in the brain and gut, effecting brain
metabolic, vascular and cognitive functions, which may increase
the risk for developing AD.
MATERIALS AND METHODS
Animals
Young (5–6 months) and old (18–20 months) male C57BL/6N
mice were acquired from the National Institute of Aging Colony.
We determined the sample size via power analysis to ensure
comparison at a 0.05 level of significance and 90% chance of
detecting a true difference of each measured variable between the
two groups. Each mouse was caged individually and housed in
a specific pathogen-free facility. In order to avoid the potential
for aggression when combining multiple male mice into one
cage, mice were housed individually. Further, mice should be
housed individually for gut microbiome analysis due to cage
effects from microbiome transfer, e.g., mice eating each other’s
feces giving them a very similar gut microbiome and thus, the
mice would be N = 1 for that particular cage (Laukens et al.,
2016). The mice were weighed weekly and given ad libitum access
to food and water. All experimental procedures were performed
according to NIH guidelines and approved by the Institutional
Animal Care and Use Committee (IACUC) at the University of
Kentucky (UK).
Gut Microbiome Analysis
Fecal DNA Amplification
Fecal samples were collected from young (N = 39) and old
(N = 28) mice and frozen at−80◦C until further use. A PowerSoil
DNA Isolation Kit (MO BIO Laboratories, Inc.) was used for
fecal DNA extraction, according to the manufacturer’s protocol.
Genomic DNA was PCR amplified with primers CS1_515F and
CS2_926R (Walters et al., 2015) targeting the V4-V5 regions
of microbial 16S rRNA genes using a two-stage ‘‘targeted
amplicon sequencing (TAS)’’ protocol (Bybee et al., 2011; Green
et al., 2015). First stage amplifications were performed with the
following thermocycling conditions: 95◦C for 3 min, 28 cycles
of 95◦C for 45 s, 55◦C for 45 s, 72◦C for 90 s and final
elongation at 72◦C for 10 min. Barcoding was performed using
a second-stage PCR amplification with Access Array Barcode
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Library for Illumina Sequencers (Fluidigm, South San Francisco,
CA, USA; Item# 100-4876). The pooled libraries, with a 15%
phiX spike-in, were loaded on a MiSeq v3 flow cell, and
sequenced using an Illumina MiSeq sequencer, with paired-end
300 base reads. Fluidigm sequencing primers, targeting the
CS1 and CS2 linker regions, were used to initiate sequencing.
De-multiplexing of reads was performed on instrument. Second
stage PCR amplification and library pooling was performed at
the DNA Services (DNAS) facility, Research Resources Center
(RRC), University of Illinois at Chicago (UIC). Sequencing
was performed at the W.M. Keck Center for Comparative and
Functional Genomics at the University of Illinois at Urbana-
Champaign (UIUC).
Microbial Analysis
Forward and reverse reads were merged using PEAR (Zhang
et al., 2014). Primer sequences were identified using Smith-
Watermann alignment and trimmed from the sequence. Reads
that lacked either primer sequence were discarded. Sequences
were then trimmed based on quality scores using a modified
Mott algorithm with PHRED quality threshold of p = 0.01, and
sequences shorter than 300 bases after trimming were discarded.
QIIME v1.8 was used to generate operational taxonomic unit
(OTU) tables and taxonomic summaries (Caporaso et al., 2010).
Briefly, the resulting sequence files were merged with sample
information. OTU clusters were generated in a de novo manner
using the UCLUST algorithm with a 97% similarity threshold
(Edgar, 2010). Chimeric sequences were identified using the
USEARCH61 algorithm with the GreenGenes 13_8 reference
sequences (McDonald et al., 2012). Taxonomic annotations for
each OTU were using the UCLUST algorithm and GreenGenes
13_8 reference with a minimum similarity threshold of 90%
(Edgar, 2010; McDonald et al., 2012). Taxonomic and OTU
abundance data were merged into a single OTU table and
summaries of absolute abundances of taxa were generated for all
phyla, classes, orders, families, genera and species present in the
dataset. The taxonomic summary tables were then rarefied to a
depth of 10,000 counts per sample.
Shannon and Bray-Curtis indices were calculated with default
parameters in R using the vegan library (Ihaka and Gentleman,
1996; Oksanen et al., 2007). The rarefied species data, taxonomic
level 7, were used to calculated both indices. Plots were generated
in R using the ggplot2 library (Hadley, 2016; Sievert et al., 2016).
Significant difference among tested groups was determined using
the Kruskal-Wallis one-way analysis of variance (ANOVA). The
group significance tests were performed on the rarefied species
data, taxonomic level 6 (genus), using the group_significance.py
script within the QIIME v1.8 package.
The gene amplicon sequence data generated as part of this
study have been submitted to the NCBI BioProject database
under accession number (PRJNAXXXXX; to be determined).
Behavior Testing
All behavior tests were conducted over a 2-week period with each
test starting at the same time each morning. For each mouse,
Elevated Plus Maze (EPM) was done first followed by Novel
Object Recognition (NOR) the next day. Radial Arm Water
Maze (RAWM) testing was then carried out starting the day
after NOR.
Elevated Plus Maze
A subset of young (N = 22) and old (N = 18) mice underwent
three behavior tests.
The first test is the EPM. We used EPM to evaluate anxiety of
the mice (Bachstetter et al., 2014; Parikh et al., 2016), which was
also performed at Rodent Behavioral Core (RBC) at the UK. The
EPM consists of two open and two closed arms elevated 100 cm
above the floor. Closed arms are perceived as safe zones, and
thus mice with higher anxiety had tendency to stay in the closed
arms. We determined the anxiety-related behavior by measuring
the time spent in the closed arms over the 5-min test session by
EthoVision XT 8.0 video tracking software.
Novel Object Recognition
The second behavioral test is the NOR, also performed in the
RBC at the UK. NOR test is used to test spatial recognition
memory (Lin et al., 2013). This task of recognition memory
utilizes the fact that animals will spend more time exploring a
novel object compared to an object that they are familiar with in
order to satisfy their innate curiosity/exploratory instinct. Mice
were given 15 min to explore two of the same objects in the
‘‘A/A’’ session. For the 10-min ‘‘A/B’’ test session, one of the
A objects was replaced by a novel object (B). There was a 2-h
delay between the A/A and A/B sessions. The total time mice
spend investigating the objects was recorded and scored by the
fully automated EthoVision XT 8.0 video tracking software. The
D2 discrimination index was calculated by: D2 = (TB − TA)
÷ (TB + TA), where TB is the time spent with the novel object
B, and TA is the time spent with the familiar object A.
Radial Arm Water Maze
The third test is the RAWM, which is used to measure
both spatial working memory and spatial reference memory
(Arendash et al., 2001; Sood et al., 2007; Parikh et al., 2016).
The RAWM task was conducted in the RBC at the UK as
described previously (Guo et al., 2015), following a 2-day testing
paradigm. A staggered training schedule was used, running the
mice in cohorts of ten mice, while alternating the different
cohorts through the trials over day 1 and day 2 of the test. This
alternating protocol was used to avoid the learning limitations
imposed by massed sequential trials and to avoid fatigue that may
result from consecutive trials. Day 1 is the ‘‘learning’’ phase where
mice went through three blocks (Blocks 1–3; 5 trials in each
block) to test learning and short-term spatial memory. Day 2 is
the ‘‘recall’’ phase where mice went through three additional
blocks (Blocks 4–6) to test long-term memory after a 24-h
retention period to locate the platform. It is expected that after
the 2-day training, the mouse with intact memory can find the
platform with minimal errors. Geometric extra-maze visual cues
were fixed throughout the study on three sides of the curtains.
Visual platform trials were included in the training and were
used to determine if visual impairment could be a cofounding
variable. Mouse performance was recorded by EthoVision XT
8.0 video tracking software (Noldus Information Technology)
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data analyzed by the EthoVision software for the number of
incorrect arm entries, which are defined as errors. The video was
reviewed for each mouse to ensure that the mice did not employ
non-spatial strategies, such as chaining, to solve the task.
Cerebral Blood Flow Measurement
A subset of young and old mice (N = 12 per group) were used to
measure in vivo CBF using magnetic resonance imaging (MRI).
MRI experiments were performed on a 7T MR scanner (Clinscan,
Bruker BioSpin, Germany) at the MRI and Spectroscopy Center
at the UK. Mice were anesthetized with 4.0% isoflurane for
induction and then maintained in a 1.2% isoflurane and air
mixture using a nose cone. Respiration rate (50–80 breaths/min)
and rectal temperature (37± 1◦C) were continuously monitored
and maintained. T2-weighted structural images were acquired
with field of view (FOV) = 18 × 18 mm2, matrix = 256 × 256;
slice thickness = 1 mm, 10 slices, repetition time (TR) = 1500 ms
and echo time (TE) = 35 ms. Quantitative CBF (with units
of mL/g per minute) was measured using MRI-based pseudo-
continuous arterial spin labeling (pCASL) techniques (Parikh
et al., 2016). A whole body volume coil was used for transmission
and a mouse brain surface coil was placed on top of the head
for receiving. Paired control and label images were acquired
in an interleaved fashion with a train of Hanning window-
shaped radiofrequency pulses of duration/spacing = 200/200 µs,
flip angle = 25◦ and slice-selective gradient = 9 mT/m, and a
labeling duration = 2100 ms (Hong et al., 2015). The images were
acquired by 2D multi-slice spin-echo echo planner imaging with
FOV = 18× 18 mm2, matrix = 128× 128, slice thickness = 1 mm,
10 slices, TR = 4000 ms, TE = 35 ms and 120 repetitions. pCASL
image analysis was employed with in-house written codes in
MATLAB (MathWorks, Natick, MA, USA) to obtain quantitative
CBF (Alsop et al., 2015).
Blood-Brain Barrier Function
Determination and Western Blotting
BBB function was determined by measuring P-glycoprotein
(P-gp) transport activity in isolated brain capillaries. P-gp is
an ATP-driven transporter highly expressed at the BBB that
facilitates transport of Aβ from brain to blood. We previously
established a confocal imaging-based assay to assess P-gp
transport activity in freshly isolated brain capillaries from
mice (Hartz et al., 2010, 2016). This assay measures within
capillary lumens accumulation of [N-ε(4-nitro-benzofurazan-
7-yl)-D-Lys(8)]-cyclosporin A (NBD-CSA), a fluorescent P-gp
substrate.
Capillary Isolation
After euthanasia, mouse brain capillaries (N = 10 per group) were
isolated according to a previously described protocol (Hartz et al.,
2010, 2012). Briefly, mice were euthanized by CO2 inhalation and
decapitated; brains were immediately harvested and collected in
ice-cold DPBS buffer supplemented with 5 mM D-glucose and
1 mM Na-pyruvate, pH 7.4. Brains were dissected by removing
meninges, choroid plexus and white matter, and homogenized
in DPBS. The brain homogenate was mixed with Ficollr and
centrifuged at 5800 g for 20 min at 4◦C. The capillary pellet was
resuspended in 1% BSA buffer and first passed through a 300µm
nylon mesh and then through a 27 µm nylon mesh. Capillaries
retained by the 27 µm nylon mesh were collected and washed
with DPBS buffer and used for experiments.
P-glycoprotein Transport Activity
Isolated capillaries were incubated for 1 h at room temperature
with 2 µM NBD-CSA (custom-synthesized by R. Wenger (Basel,
Switzerland)) in DPBS buffer. Ten capillary images were acquired
by confocal microscopy (Leica TSP SP5 Confocal Microscope
with Environmental Chamber, 63× D-Water UV objective,
numerical aperture 1.2, Zoom: 4, 488-nm line of an argon
laser, Leica Microsystems). Confocal images were analyzed
by quantitating luminal NBD-CSA fluorescence with ImageJ
software (v.1.45s; Wayne Rasband, NIH). Specific, luminal
NBD-CSA fluorescence was taken as the difference between
total luminal fluorescence and fluorescence in the presence
of the P-gp-specific inhibitor PSC833 (5 µM, Novartis, Basel,
Switzerland; Miller et al., 2008).
Western Blotting and Quantification
To determine protein expression, isolated brain capillaries were
homogenized in tissue lysis buffer containing a cocktail of
protease inhibitors. Homogenized brain capillary samples were
centrifuged at 10,000 g for 15 min at 4◦C, followed by a
centrifugation of the denucleated supernatants at 100,000 g
for 90 min at 4◦C. Pellets (crude brain capillary plasma
membranes) were resuspended and protein concentrations were
determined using the Bradford protein assay. Normalized brain
capillary membrane samples were separated on a NuPAGETM
4%–12% Bis-Tris Protein Gels (1.0 mm, 15-wells; Thermo
Fisher Scientific, Waltham, MA, USA) and transferred onto a
InvitrolonTM PVDF membrane (0.45 µm pore size; Thermo
Fisher Scientific, Waltham, MA, USA) membrane using the
NuPAGEr electrophoresis and blotting system (Invitrogen,
Carlsbad, CA, USA). After protein transfer, the blotting
membranes were incubated overnight with antibody to P-gp
(C219; MA1-26528, ThermoFisher, 1 µg/ml) and β-actin
(ab8226 from Abcam, 1:1000, 1 µg/ml). Proteins were detected
using SuperSignalr West Pico Chemoluminescent substrate
(Pierce, Rockford, IL, USA) and protein bands were visualized
with a BioRad Gel DocTM XRS imaging system. P-gp was
visualized first, membranes were then stripped with RestoreTM
Western Blot Stripping Buffer (Thermo Fisher Scientific,
Waltham, MA, USA) and incubated with the antibody against
β-actin. Image Lab 5.0 software from Bio-Rad Laboratories was
used for densitometric analyses of band intensities and digital
molecular weight analyses; the molecular weight marker was
RPN800E (GE Healthcare, Chalfont St. Giles, Buckinghamshire,
UK). Linear adjustments of contrast and brightness were applied
to entire Western blot images. None of the Western blots shown
were modified by nonlinear adjustments.
Inducible Nitric-Oxide Synthase
Measurement
Total RNA from frontal cortex and hypothalamus homogenate
(N = 7–8 per group) was isolated using TRI Reagent solution
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(Ambion), and cDNA was synthesized from 1 µg total
RNA from each individual sample using SuperScript III
(Invitrogen). qRT-PCR was performed using TaqMan real
time PCR (ViiATM7, Applied Biosystems). All reactions
were performed with non-template negative control, and
all data are mean ± SEM of two independent biological
replicates. The gene probes and master mix were also
purchased from Applied Biosystems. The probe sets were
as follows: Mm00440502-m1 (iNOS Nos2), Mm00446968-m1
(hypoxanthine guanine phosphoribosyl transferase, Hprt).
The relative expression levels were measured using the
relative quantitation ∆Ct (delta counts) method and
normalized to Hprt.
Metabolomic Profiling
A subset of mice was euthanized after 2- and 6-h of feeding
(N = 6 and 4 for young and old mice, respectively) with
subsequent collection of their whole brain. The brains were then
sent to Metabolon (Durham, NC, USA) for analysis of brain
metabolomic profile. Metabolon’s standard solvent extraction
method was used to prepare the samples, which were then equally
split for analysis via liquid chromatography/mass spectrometry
(LC/MS) or gas chromatography/mass spectrometry (GC/MS)
using their standard protocol (Evans et al., 2009).
Sample Preparation
Each sample was accessioned into a LIMS system, assigned a
unique identifier, and stored at −70◦C. To remove protein,
dissociate small molecules bound to protein or trapped in the
precipitated protein matrix, and to recover chemically diverse
metabolites, proteins were precipitated with methanol, with
vigorous shaking for 2 min (Glen Mills Genogrinder 2000) as
described previously (Evans et al., 2009; Weiner et al., 2012). The
resulting extract was divided into four fractions: one for analysis
by ultra high performance liquid chromatography-tandem mass
spectrometry run in positive mode (UPLC-MS/MS+), one
for analysis by UPLC-MS/MS run in negative mode (UPLC-
MS/MS−), one for analysis by GC-MS, and one aliquot was
retained for backup analysis, if needed.
Mass Spectrometry Analysis
Non-targeted UPLC-MS/MS and GC-MS analyses were
performed at Metabolon, Inc. as described (Evans et al., 2009;
Sha et al., 2010; Weiner et al., 2012). The UPLC/MS/MS portion
of the platform incorporates a Waters Acquity UPLC system
and a Thermo-Finnegan LTQ mass spectrometer, including
an electrospray ionization (ESI) source and linear ion-trap
(LIT) mass analyzer. Aliquots of the vacuum-dried sample
were reconstituted, one each in acidic or basic LC-compatible
solvents containing eight or more injection standards at fixed
concentrations (to both ensure injection and chromatographic
consistency). Extracts were loaded onto columns (Waters UPLC
BEH C18-2.1 × 100 mm, 1.7 µm) and gradient-eluted with
water and 95% methanol containing 0.1% formic acid (acidic
extracts) or 6.5 mM ammonium bicarbonate (basic extracts).
The instrument was set to scan 99–1000 m/z and alternated
between MS and MS/MS scans.
Samples destined for analysis by GC-MS were dried under
vacuum desiccation for a minimum of 18 h prior to being
derivatized using bis(trimethylsilyl)trifluoroacetamide (BSTFA)
as described (Ohta et al., 2009). Derivatized samples were
separated on a 5% phenyldimethyl silicone column with helium
as carrier gas and a temperature ramp from 60◦C to 340◦C
within a 17-min period. All samples were analyzed on a
Thermo-Finnigan Trace DSQ fast-scanning single-quadrupole
MS operated at unit mass resolving power with electron impact
ionization and a 50–750 atomic mass unit scan range. The
instrument is tuned and calibrated for mass resolution and mass
accuracy daily.
Quality Control
All columns and reagents were purchased in bulk from a
single lot to complete all related experiments. For monitoring
of data quality and process variation, multiple replicates of
extracts from a pool of human plasma were prepared in
parallel and injected throughout the run, interspersed among the
experimental samples. Instrument variability was determined by
calculating the median relative standard deviation (RSD) for the
standards that were added to each sample prior to injection into
the mass spectrometers (median RSD = 4%; n = 21 standards).
Overall process variability was determined by calculating the
median RSD for all endogenous metabolites (i.e., non-instrument
standards) present in 100% of technical replicate samples created
from a homogeneous pool containing a small amount of all
study samples (median RSD = 6%; n = 170 metabolites). In
addition, process blanks and other quality control samples
are spaced evenly among the injections for each day, and all
experimental samples are randomly distributed throughout each
day’s run.
Compound Identification, Quantification and Data
Curation
Metabolites were identified by automated comparison of the
ion features in the experimental samples to a reference
library of chemical standard entries that included retention
time, molecular weight (m/z), preferred adducts and in-source
fragments as well as associated MS spectra and curated by
visual inspection for quality control using software developed
at Metabolon (Dehaven et al., 2010). Identification of known
chemical entities was based on comparison to metabolomic
library entries of more than 2800 commercially-available purified
standards. Subsequent QC and curation processes were utilized
to ensure accurate, consistent identification and to minimize
system artifacts, mis-assignments and background noise. Library
matches for each compound were verified for each sample.
Peaks were quantified using area under the curve. Raw area
counts for each metabolite in each sample were normalized to
correct for variation resulting from instrument inter-day tuning
differences by the median value for each run-day, therefore
setting the medians to 1.0 for each run. This preserved variation
between samples, but allowed metabolites of widely different
raw peak areas to be compared on a similar graphical scale.
Missing values were imputed with the observed minimum after
normalization.
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Bioinformatics
The LIMS system encompasses sample accessioning,
preparation, instrument analysis and reporting and advanced
data analysis. Additional informatics components include data
extraction into a relational database and peak-identification
software; proprietary data processing tools for QC and
compound identification; and a collection of interpretation
and visualization tools for use by data analysts. The hardware
and software systems are built on a web-service platform utilizing
Microsoft’s .NET technologies which run on high-performance
application servers and fiber-channel storage arrays in clusters
to provide active failover and load-balancing.
Statistical Analysis
All statistical analyses were completed using GraphPad Prism
(GraphPad, San Diego, CA, USA). One-tailed Student’s t-test
was performed for determination of differences between groups.
Levels of statistical significance were reached when p < 0.05.
For Metabolon, missing values in the data are assumed to
be below the level of detection of the used instruments. Log
transformations and imputation of missing values with the
minimum observed values for each metabolite was conducted.
This was followed by ANOVA to identify biochemicals that
were significantly different between groups. Given the multiple
comparisons inherent in analysis of metabolites, between-group
relative differences are assessed using both p-value and false
discovery rate analysis (q-value).
RESULTS
Altered Gut Microbiome and Increased
Body Weight with Age
Alpha diversity (e.g., Shannon index, H value) was measured for
fecal microbial communities of all samples, at the taxonomic level
of genus (Figure 1A). Older mice had a significantly higher alpha
diversity than young mice (Kruskal-Wallis p-value = 0.022).
Although no significant differences in beta diversity were
observed (analysis of similarity, ANOSIM R statistic = 0.006,
p-value = 0.307, 999 permutations), and no specific taxa were
significantly different between the groups of young and old
mice (Kruskal-Wallis, false discovery rate, FDR-corrected
p-value < 0.05), the ratio of Firmicutes/Bacteroidetes was
significantly different between age groups. Old mice had
significantly higher Firmicutes/Bacteroidetes (F/B) ratio
(Figure 1B, 46% increase, p < 0.05). Further, we found that the
body weight of the old mice was significantly higher compared
with that of the young mice (Figure 1C, 24% increase, p< 0.05).
Enhanced Proinflammatory Metabolism
with Age
The quantification of the brain metabolites is shown in Table 1.
We observed several significant age-dependent changes in basal
brain metabolites (after 6 h of final feeding). Notably, the old
group had a 31%–83% change in markers of the methionine
cycle with significantly greater methionine, cysteine, cysteine-
glutathione disulfide and cystathionine. First, methionine
is an amino acid that may be accountable for increased
mitochondrial reactive oxygen species (ROS; Pamplona and
Barja, 2006). Due to this, we believe the old mice exhibit
increased oxidative stress in the brain. We also found lipids
related to inflammatory responses significantly elevated in
the old mice, including a 82% increase in prostaglandin D2
and a 80% increase in prostaglandin E2. Further, markers
associated with AD were significantly greater in the old
mice compared to the young, including a 21% increase in
24(S)-hydroxycholesterol, 28% increase in mead acid (20:3n9),
37% increase in phenylalanine, 58% increase in spermidine,
22% increase in docosapentaenoate (n6 DPA; 22:5n6), 11%
increase in creatine and 12% increase in phosphocholine
(Morrison and Kish, 1995; Geddes et al., 1997; Lütjohann
et al., 2000; García-Calatayud et al., 2005; Gallant et al., 2006;
Astarita et al., 2011; Wissmann et al., 2013). In contrast,
CDP-choline, a metabolite that has shown to alleviate AD
symptoms (Alvarez et al., 1999), saw a 6% decrease in
the old group. In addition, old mice also demonstrated a
114% increase in citrate. Collectively, the metabolic profiling
indicates that the old mice had enhanced proinflammatory
metabolism. These data are consistent with our observation of
FIGURE 1 | (A) The old mice showed a higher alpha-diversity, as indicated by the Shannon index, than the young mice (p = 0.02). Compared with the young mice,
the old mice had significantly increased (B) Firmicutes/Bacteroidetes ratio and (C) body weight. N = 39 and 28 for young and old mice, respectively. Data are
presented as mean ± SEM.
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TABLE 1 | The metabolomics profiling of brain metabolites is drastically modified with age.
Classification Metabolite P Young Old
Amino acids Creatine 0.003 0.990 ± 0.022 1.101 ± 0.017
Cystathionine 0.026 0.943 ± 0.072 1.316 ± 0.174
Cysteine 0.007 1.023 ± 0.138 1.873 ± 0.262
Cysteine-glutathione disulfide 0.013 1.008 ± 0.132 1.736 ± 0.267
Methionine 0.001 0.915 ± 0.047 1.204 ± 0.015
Phenylalanine 0.002 0.917 ± 0.042 1.255 ± 0.085
Spermidine 0.016 0.910 ± 0.059 1.436 ± 0.238
Cofactors and vitamins Citrate 0.008 0.867 ± 0.099 1.860 ± 0.381
lipids 24(S)-hydroxycholesterol 0.025 0.939 ± 0.027 1.135 ± 0.098
CDP-choline 0.037 1.002 ± 0.014 0.944 ± 0.028
Docosapentaenoate (n6 DPA; 22:5n6) 0.007 0.994 ± 0.019 1.215 ± 0.085
Mead acid (20:3n9) 0.025 1.070 ± 0.068 1.367 ± 0.122
Phosphocholine 0.024 1.076 ± 0.029 1.206 ± 0.054
Prostaglandin D2 0.009 0.682 ± 0.087 1.238 ± 0.193
Prostaglandin E2 0.007 0.746 ± 0.076 1.341 ± 0.207
Representative data, shown in scaled intensity, of the young and old groups. Data are mean ± SEM.
FIGURE 2 | (A) The old mice had a significant increase in inducible nitric oxide synthase (iNOS) in the brain compared to the young mice (N = 7–8 per group). The
old mice had acute elevations (2 h after feeding) in (B) 3-indoxyl sulfate and (C) phenol sulfate; those levels returned to baseline 4 h later (N = 6 and 4 for young and
old mice, respectively).
significantly increased iNOS levels in the brain of old mice
compared to that of young mice (Figure 2A, 17% increase,
p = 0.02).
We found that two of the brain metabolites related to
gut microbiota were also significantly different between
young and old cohorts. Compared to the young mice,
old mice had significantly higher 3-indoxyl sulfate
(Figure 2B, 380% increase, p < 0.05) and phenol sulfate
(Figure 2C, 144% increase, p < 0.05) in their brain
within 2 h after their final feeding, however, the levels
of the two metabolites returned to the baseline after 6 h
of feeding. 3-indoxyl sulfate is generated in the liver as
a result of gut microbiome metabolism of tryptophan;
phenol sulfate is a metabolite derived from bacterial
metabolism of phenylalanine. The results suggest that the
gut microbiome may play an important role in modulating
brain metabolism. Because 3-indoxyl sulfate and phenol sulfate
both are related to neurological toxicity and inflammation
(Zgoda-Pols et al., 2011; Weber et al., 2015), it implies
that old mice had higher neuroinflammation, which
may of resulted from age-dependent changes in the gut
microbiota.
Impaired Neurovascular Functions with
Age
We found impaired BBB function in the old mice. Figure 3A
shows representative confocal images of capillaries; the intensity
of fluorescence in the capillary lumen reflects the amount of
P-gp, an efflux transporter of Aβ. The corresponding quantitative
results are shown in Figure 3B; the old mice had significantly
reduced P-gp transport activity (p = 0.0031) compared to the
young mice. We also measured P-gp protein expression levels
(Figure 3C). Similar to the results of P-gp activity, we found
that the old mice had significant reduction in P-gp protein levels
compared to the young mice (decrease to 63.7 ± 5.4% over
100% young; p < 0.001; Figure 3C). We also observed reduced
CBF in the old mice. Figure 3D shows the representative CBF
images of the young and old mice. The CBF level is colorized
in a linear scale, indicating that the young mice have overall
higher CBF compared to the old mice, which was confirmed
by the quantitative global CBF values (Figure 3E, 87% increase,
p < 0.001). We did further CBF analyses in brain regions
associated with cognitive functions (e.g., memory and learning)
based on MRI structural imaging and mouse brain atlas. We
found that young mice exhibited an 82% increase in CBF in
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FIGURE 3 | (A) Representative confocal images showing decreased luminal accumulation of N-ε(4-nitro-benzofurazan-7-yl)-D-Lys(8)-cyclosporin A (NBD-CSA)
fluorescence (white) in brain capillaries isolated from the old mice compared to young mice, indicating reduced P-glycoprotein (P-gp) activity. (B) Corresponding
quantitative fluorescence data; images are shown in arbitrary fluorescence units (scale 0–255). Data are mean ± SEM for 10 capillaries from one preparation of
10 mice. (C) Western blotting (WB) for P-gp from the cortical vasculature, β-Actin was used as loading control (top); corresponding values are shown in the table
(bottom). The WB data from the old mice were normalized to β-Actin and compared to the young mice (100%), ∗∗p < 0.01. (D) Cerebral blood flow (CBF) maps
superimposed on structural images; the color code indicates the level of CBF on a linear scale. Quantitative CBF (ml/g/min) obtained from (E) the whole brain and
(F) hippocampus (N = 12 per group). Data are mean ± SEM.
FIGURE 4 | (A) The elevated plus maze (EPM) found the old mice to have a significantly higher closed arm duration compared to the young group. (B) The Novel
Object Recognition (NOR) test found the old group had a significantly lower recognition index, or D2, than the young group. (C) The average errors made by the
young and old mice during the Radial Arm Water Maze (RAWM) split into six blocks. The significant difference between the two groups in average errors corrected
showing in Block 3 (p = 0.0307) and Block 4 (p = 0.0045). N = 22 and 18 for young and old mice, respectively. Data are presented as mean ± SEM. ∗∗p < 0.05.
the hippocampus (p < 0.001, Figure 3F), compared to the old
mice.
Compromised Cognition and Increased
Anxiety with Age
The old mice spent significantly longer time in the closed arms
compared to the young mice in the EPM test (Figure 4A, 132%
increase, p< 0.0001), indicating higher anxiety. In the NOR test,
the old mice showed a significantly lower D2 value compared
to the young group, suggesting reduced recognition memory
(Figure 4B, −74% decrease, p < 0.0001). In the RAWM test, the
old group made significantly more errors in the learning phase
(Block 3; 46% increase, p < 0.01) and the initial recall phase
(Block 4; 43% increase, p < 0.01), compared to the young group
(Figure 4C).
DISCUSSION
In this study, we demonstrated the age-dependent changes
in brain metabolism, gut microbiome, vascular functions,
memory and anxiety. Specifically, aged mice had enhanced
proinflammatory, increased ratio of Firmicutes to Bacteroidetes,
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increased bacterial alpha diversity and body weight, impaired
BBB and CBF, compromised learning and long-term memory,
and increased anxiety. These deleterious changes in aging have
the potential to increase the risk for neurological disorders and
dementia, including AD.
We found several amino acid increased in the old mice
that are highly associated with AD, including spermidine,
phenylalanine, creatine citrate and methionine-related
metabolites. First, spermidine levels have been found to be higher
in the temporal cortex with a trending elevation in hippocampus
and frontal cortex in AD patients, potentially as a response
to brain injury (Morrison and Kish, 1995). Excess spermidine
could exacerbate neurodegeneration as it positively modulates
N-methyl-D-aspartate (NMDA) glutamate receptor function and
disrupt calcium homeostasis. Second, high phenylalanine levels
are also found in AD patients, associated with immune activation
(Wissmann et al., 2013). Phenylalanine disturbs neopterin and
tryptophan metabolism, which is correlated with cognitive
impairment (Keegan et al., 2016; Palermo et al., 2017). Third,
old mice had higher creatine deposits in the brain, consistent
with literature that creatine metabolism malfunction plays an
important role in AD (Gallant et al., 2006). Fourth, old mice had
increased levels of citrate in the brain suggesting increased usage
of fatty acid synthesis for membrane remodeling associated
with aging due to the increased stress and inflammation that
damage neuronal membranes (Curi et al., 2017). Finally,
the old mice had altered methionine-associated metabolism,
including increased methionine, cystathionine, cysteine and
cysteine-glutathione disulfide. Excessive methionine has been
considered to be accountable for increased mitochondrial
ROS production, which in turn enhances oxidative stress and
inflammation (Jaeschke, 2011; Schweinberger and Wyse, 2016;
Palermo et al., 2017). Interestingly, previous studies have shown
that methionine restriction can lead to increased longevity by
decreasing mitochondrial complex IV activity and accumulation
of ROS (Kozieł et al., 2014; Brown-Borg, 2016).
Accumulation of lipids in the brain is another hallmark of
AD (Alzheimer et al., 1995). In the present study, we also found
AD-associated fatty acids increased in the aged mice. First,
24(S)-hydroxycholesterol, an oxidized product of cholesterol
produced in the brain, has been demonstrated to be elevated
in AD patients and is hypothesized to be an early marker for
distorted cholesterol status (Lütjohann et al., 2000). Second,
phosphocholine has been revealed to be increased in rats during
the early stages of AD during lesion-induced neuronal sprouting
in the hippocampus (Geddes et al., 1997). This indicates that
sprouting may occur early on in AD with phosphocholine as
a marker. In addition, sprouting may also lead to a decline
in energy metabolism due to energy being used for sprouting,
consistent with the evidence of glucose metabolism decline
in AD. Third, mead acid (20:3n9), an omega-9 fatty acid,
has been demonstrated to be increased in the mid-frontal
cortex, temporal cortex and hippocampus of AD patients
(Astarita et al., 2011). Fourth, docosapentaenoate (n6 DPA), an
omega-6 fatty acid, has been inversely correlated with learning
(García-Calatayud et al., 2005). This is consistent with previous
findings that oleic acid-enriched triglycerides were found in the
brain of a triple transgenic mice model of AD (3xTg-AD); but
when the triglycerides were inhibited, proper brain function
was restored (Hamilton et al., 2015). Further, prostaglandin
D2 and E2, produced from arachidonate, are generators of an
inflammatory response and present in increased amounts in such
an event, were also elevated in the old group (Ricciotti and
Fitzgerald, 2011). Specifically in one study, prostaglandin E2 was
associated with neuronal oxidative damage after activation by
lipopolysaccharide (LPS; Montine et al., 2002). LPS also can
activate iNOS, which is consistent with our finding that old
mice had significantly increased iNOS expression in the brain. In
contrast, the aged mice showed reduced levels of CDP-choline,
which has shown to alleviate AD symptoms by increasing CBF
and brain electrical activity, and reducing serum cytokine IL-1β
levels (Alvarez et al., 1999). Old mice also had dramatically
decreased levels of glycerophopshorylcholine (GPC), which has
been used to treat patients with cognitive impairment and AD
(Parnetti et al., 2007). Collectively, old mice exhibited a myriad
of markers associated with inflammation and AD.
The enhanced inflammation with age may have also occurred
in the gut. We found that 3-indoxyl sulfate and phenol sulfate,
which originate from the gut microbiota, were significantly
elevated in the aged mice’s brains after meals. Significant
increases of indoxyl sulfate have shown to enhance neurological
toxicity, increase oxidative stress and ROS, and induce
endothelial dysfunction by inhibiting endothelial proliferation
and migration in vitro (Brunet et al., 2003; Dou et al., 2007).
In addition, phenol sulfate is derived from bacterial metabolism
of phenylalanine, a marker for AD, as mentioned above. Next,
we found a modest increase in older mice in the relative
abundance of sequences from bacteria of the phylum Firmicutes,
with a concomitant decrease in the relative abundance of
sequences from bacteria of the phylum Bacteroidetes. Although
neither change was statistically significant, the overall change,
leading to an increased Firmicutes/Bacteroidetes (F/B) ratio in
older mice, was significant. As bacteria from the Firmicutes
have been associated with weight-gain and those within the
Bacteroidetes with weight-loss, this increased F/B ratio may
promote body weight gain in old mice (Turnbaugh et al., 2006).
Further, this increased F/B ratio may lead to excessive low-grade
inflammation and a substantial increase in energy harvesting
and food intake (Cani et al., 2012; Harris et al., 2012). As
a result, the F/B ratio has become a well-known marker for
obesity and Type 2 Diabetes Mellitus (T2DM; Walters et al.,
2014). Interestingly, AD has been called Type 3 diabetes due
to the overlapping symptoms observed in T2DM, e.g., insulin
resistance and increased inflammation in the brain (de la Monte
and Wands, 2008), along with an increased risk of dementia
(Vagelatos and Eslick, 2013). Thus, the increased F/B ratio may
be indicative of an increased risk for AD.
Short-chain fatty acids (SCFAs), including butyrate and
propionate that are produced by certain bacterial species, have
a dramatic impact on brain function. For example, butyrate
has been demonstrated to prevent inflammatory responses via
NFκB inhibition in microglia and hippocampal slice cultures
(Huuskonen et al., 2004). Also, indole-3-proprionic acid (IPA),
another metabolite produced by the gut microbiome, was
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demonstrated to inhibit Aβ fibril formation in neurons and
neuroblastoma cells (Chyan et al., 1999). On the contrary,
increased Firmicutesmay enhance trimethylamine (TMA) and its
co-metabolites trimethylamine N-oxide (TMAO; Martínez-del
Campo et al., 2015). TMAO level predicts risk for atherosclerosis
and directly induces cardiovascular disease (Wang et al., 2011,
2014; Bennett et al., 2013; Zhang and Davies, 2016).
Reduced SCFAs has been shown to induce BBB permeability
(Braniste et al., 2014). This is consistent with our findings that
BBB function was compromised in the old mice. Specifically, we
found the old mice had a significantly lower quantity of P-gp
transporters in BBB, which are responsible for Aβ clearance from
the brain to blood, indicative of an increased risk of developing
AD (Cirrito et al., 2005). BBB breakdown has been caused by
elevated neuroinflammation (Bell et al., 2012) and is associated
with CBF reduction. In line with this, we found decreased CBF
in old mice. In particular, old mice had significantly decreased
CBF in the hippocampus, the brain region that modulates
cognitive function. Further, the old mice performed worse in
the RAWM and NOR behavior tests than the young animals.
Specifically, the old group performed worse in Block 3 and 4 of
the RAWM compared to the young group, exhibiting inhibited
spatial learning and long-term memory formation, consistent
with our previous findings (Guo et al., 2015; Parikh et al., 2016).
In the NOR test, the old group had a worse D2 score compared
to the young group, indicating a worse recognition memory.
Taken together, our findings are consistent with the literature
where impaired neurovascular integrity plays a critical role in
determining cognitive functions (Birdsill et al., 2013).
Higher anxiety levels were shown in old mice compared to
young mice, which may be also associated with brain vascular
and metabolic dysfunctions (Gur et al., 1987; Ebmeier et al., 1997;
Park and Moghaddam, 2017). Interestingly, the gut microbiome
has been linked with anxiety (Foster and McVey Neufeld, 2013).
Indeed, the gut and brain are connected via the enteric nervous
system and have bi-directional communication, impacting
behavior (Schnorr and Bachner, 2016). Certain bacterial species
such as L. rhamnosus have been demonstrated to decrease
anxiety like symptoms and stress induced hormones (Bravo et al.,
2011). Studies using oral administration of food-borne pathogens
showed evidence that bacteria residing in the gastrointestinal
tract can activate stress circuits through activation of vagal
pathways (Lyte et al., 2006; Goehler et al., 2008). Exposure to
a subpathogenic infection of C. jejuni increased anxiety-like
behavioral measure in the EPM 2 days after infection (Lyte et al.,
1998). These studies clearly demonstrated that inflammatory
state could have strong influences on behavior and mental health.
Conversely, treating mice with probiotics has been shown to
reduce anxiety-like behavior; the probiotic-treated group showed
increased entries into the open arms of the EPM compared to
the control group (Casey et al., 2011). Further confirming the
importance of the gut microbiome in relation to stress, one
study demonstrated germ-free mice to have an excessive release
of stress hormones. However, when these mice were colonized
with Bifidobacterium infantis, this response was alleviated
(Sudo et al., 2004). Similar observations were also made in clinical
trials in patients with chronic fatigue, showing that anxiety-like
FIGURE 5 | Proposed associations of age-dependent changes in brain
metabolism, vascular integrity, gut microbiome, cognition and anxiety level.
Inflammation in aging, or inflammaging, might play a critical role in be a driving
the deleterious changes in the brain and gut.
symptoms were alleviated by probiotics (Rao et al., 2009). The
study findings may be applicable to AD as increased anxiety
levels and depression are commonly found preceding the onset
of AD (Ferretti et al., 2001). Modulating the gut microbiome may
thus be important for reducing risk or preventing AD and other
neurodegenerative disorders (Hill et al., 2014; Hu et al., 2016;
Fung et al., 2017; Tremlett et al., 2017).
We summarize our findings with Figure 5. It shows that
advancing age drives deleterious modifications in metabolism,
gut microbiome, neurovascular integrity, cognition and mental
health, which may significantly enhance the risk for AD. Our
study implies that inflammation may play a critical role in
the remodeling process. This is consistent with the concept
of inflammaging, the phenomenon where innate immunity
is activated, coupled with the rise of proinflammation with
advancing age (Xia et al., 2016). We suggest that, based on
our results, the inflammatory responses with age are systematic;
they may be originated from the CNS as well as the peripheral
systems, e.g., from the gut. To promote healthy aging and
prevent AD, it will thus be critical to manage low-grade, chronic
proinflammation over time.
In future studies, it is important to determine mechanisms
linking the brain and gut in the context of brain aging, including
pathways involved in SCFAs, neurotransmitters, vagus nerve
activity and immune system function. As well as, to identify
potential nutritional interventions that can promote brain-gut
interactions, such as probiotics and prebiotics.
We have recently shown that dietary interventions can delay
brain aging (e.g., caloric restriction and rapamycin) and thus,
it will be crucial in the future to determine if these dietary
interventions also have a significant impact on the brain-gut
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axis (Guo et al., 2015; Parikh et al., 2016; Lin et al., 2017). In
addition, it will be imperative to develop surrogate biomarkers
using neuroimaging. In the present study, we used MRI to
measure in vivo CBF but we have also developed imaging
methods to determine brain metabolic and anatomical integrity
(Lin et al., 2014, 2015). Further, we will also use this state-of-
the-art technology to study brain-gut axis and make our research
strategy translatable to clinical applications.
In conclusion, we found the inflammation-associated impact
on brain metabolism, gut microbiome, neurovascular functions,
memory and anxiety in aging mice. However, additional research
needs to be conducted on the gut microbiome and mechanisms
of the gut-brain axis. Understanding brain aging is imperative to
identify risks, and intervention thereof, for AD. A comprehensive
and integrative characterization of brain aging, including its
crosstalk with peripheral systems and factors, will help to define
the mechanisms underlying the shift from normal aging to
pathological processes in the etiology of AD (Hill et al., 2014;
Fung et al., 2017).
AUTHOR CONTRIBUTIONS
JDH, IP and A-LL contributed to the major design, acquisition,
analysis and interpretation of data for the work. SJG, GC, IP
and JDH contributed to the gut microbiome analysis. AMSH
and BB contributed to data acquisition and analysis related
to BBB functions. RPM and MK contributed to biostatistical
support for the metabolomic profiling. JDH, IP, SJG, GC, RPM,
AMSH, BB and A-LL drafted and revised the work for important
intellectual content, approved of the final version and agreed
to be accountable for all aspects of the work in ensuring that
questions related to the accuracy or integrity of any part of the
work are appropriately investigated and resolved.
FUNDING
This research was supported by National Institutes of Health
(NIH)/National Institute on Aging (NIA) grant K01AG040164,
NIH/NIA grant R01AG054459, NIH/CTSA grant UL1TR000117
and American Federation for Aging Research Grant #A12474 to
A-LL, NIH/NIA grant R01AG039621 to AMSH, NIH/National
Institute of Neurological Disorders and Stroke (NINDS)
grant 1R01NS079507 to BB and NIH/National Institute
of Diabetes and Digestive and Kidney Diseases (NIDDK)
Training Grant T32DK007778 to JDH. The content is solely
the responsibility of the authors and does not necessarily
represent the official views of the NIA or the NIH. The 7T
ClinScan small animal MRI scanner of the UK was funded
by the S10 NIH Shared Instrumentation Program Grant
(1S10RR029541-01).
ACKNOWLEDGMENTS
We thank Vikas Bakshi, Janet Guo, Rachel Armstrong, Chase
Thornton, Stephanie Edelmann and Ralf Rempe of the University
of Kentucky for assisting the experiments.
REFERENCES
Al-Asmakh, M., and Hedin, L. (2015). Microbiota and the control of blood-tissue
barriers. Tissue Barriers 3:e1039691. doi: 10.1080/21688370.2015.1039691
Alsop, D. C., Detre, J. A., Golay, X., Günther, M., Hendrikse, J., Hernandez-
Garcia, L., et al. (2015). Recommended implementation of arterial spin-labeled
perfusion MRI for clinical applications: a consensus of the ISMRM perfusion
study group and the European consortium for ASL in dementia. Magn. Reson.
Med. 73, 102–116. doi: 10.1002/mrm.25197
Alvarez, X. A., Mouzo, R., Pichel, V., Pérez, P., Laredo, M., Fernández-Novoa, L.,
et al. (1999). Double-blind placebo-controlled study with citicoline in APOE
genotyped Alzheimer’s disease patients. Effects on cognitive performance,
brain bioelectrical activity and cerebral perfusion. Methods Find. Exp. Clin.
Pharmacol. 21, 633–644.
Alzheimer, A., Stelzmann, R. A., Schnitzlein, H. N., and Murtagh, F. R. (1995).
An English translation of Alzheimer’s 1907 paper, ‘‘Uber eine eigenartige
Erkankung der Hirnrinde’’. Clin. Anat. 8, 429–431. doi: 10.1002/ca.980080612
Arendash, G. W., King, D. L., Gordon, M. N., Morgan, D., Hatcher, J. M.,
Hope, C. E., et al. (2001). Progressive, age-related behavioral impairments
in transgenic mice carrying both mutant amyloid precursor protein
and presenilin-1 transgenes. Brain Res. 891, 42–53. doi: 10.1016/s0006-
8993(00)03186-3
Astarita, G., Jung, K. M., Vasilevko, V., Dipatrizio, N. V., Martin, S. K.,
Cribbs, D. H., et al. (2011). Elevated stearoyl-CoA desaturase in brains of
patients with Alzheimer’s disease. PLoS One 6:e24777. doi: 10.1371/journal.
pone.0024777
Bachstetter, A. D., Webster, S. J., Tu, T., Goulding, D. S., Haiech, J.,
Watterson, D. M., et al. (2014). Generation and behavior characterization
of CaMKIIβ knockout mice. PLoS One 9:e105191. doi: 10.1371/journal.pone.
0105191
Bangen, K. J., Beiser, A., Delano-Wood, L., Nation, D. A., Lamar, M., Libon, D. J.,
et al. (2013). APOE genotype modifies the relationship between midlife
vascular risk factors and later cognitive decline. J. Stroke Cerebrovasc. Dis. 22,
1361–1369. doi: 10.1016/j.jstrokecerebrovasdis.2013.03.013
Bell, R. D., Winkler, E. A., Singh, I., Sagare, A. P., Deane, R., Wu, Z., et al. (2012).
Apolipoprotein E controls cerebrovascular integrity via cyclophilin A. Nature
485, 512–516. doi: 10.1038/nature11087
Bennett, B. J., de Aguiar Vallim, T. Q., Wang, Z., Shih, D. M., Meng, Y.,
Gregory, J., et al. (2013). Trimethylamine-N-oxide, a metabolite associated with
atherosclerosis, exhibits complex genetic and dietary regulation. Cell Metab. 17,
49–60. doi: 10.1016/j.cmet.2012.12.011
Biagi, E., Nylund, L., Candela, M., Ostan, R., Bucci, L., Pini, E., et al. (2010).
Through ageing, and beyond: gut microbiota and inflammatory status in
seniors and centenarians. PLoS One 5:e10667. doi: 10.1371/journal.pone.
0010667
Birdsill, A. C., Carlsson, C. M., Willette, A. A., Okonkwo, O. C., Johnson, S. C.,
Xu, G., et al. (2013). Low cerebral blood flow is associated with lower memory
function in metabolic syndrome. Obesity (Silver Spring) 21, 1313–1320.
doi: 10.1002/oby.20170
Boumezbeur, F., Mason, G. F., de Graaf, R. A., Behar, K. L., Cline, G. W.,
Shulman, G. I., et al. (2010). Altered brain mitochondrial metabolism in healthy
aging as assessed by in vivo magnetic resonance spectroscopy. J. Cereb. Blood
Flow Metab. 30, 211–221. doi: 10.1038/jcbfm.2009.197
Braniste, V., Al-Asmakh, M., Kowal, C., Anuar, F., Abbaspour, A., Tóth, M., et al.
(2014). The gut microbiota influences blood-brain barrier permeability in mice.
Sci. Transl. Med. 6:263ra158. doi: 10.1126/scitranslmed.3009759
Bravo, J. A., Forsythe, P., Chew, M. V., Escaravage, E., Savignac, H. M.,
Dinan, T. G., et al. (2011). Ingestion of Lactobacillus strain regulates emotional
behavior and central GABA receptor expression in a mouse via the vagus
nerve. Proc. Natl. Acad. Sci. U S A 108, 16050–16055. doi: 10.1073/pnas.
1102999108
Brown-Borg, H. M. (2016). Reduced growth hormone signaling and methionine
restriction: interventions that improve metabolic health and extend life span.
Ann. N Y Acad. Sci. 1363, 40–49. doi: 10.1111/nyas.12971
Frontiers in Aging Neuroscience | www.frontiersin.org 11 September 2017 | Volume 9 | Article 298
Hoffman et al. Age Effects on Brain and Gut
Brunet, P., Dou, L., Cerini, C., and Berland, Y. (2003). Protein-bound uremic
retention solutes. Adv. Ren. Replace. Ther. 10, 310–320. doi: 10.1053/j.arrt.2003.
08.002
Bybee, S. M., Bracken-Grissom, H., Haynes, B. D., Hermansen, R. A., Byers, R. L.,
Clement, M. J., et al. (2011). Targeted amplicon sequencing (TAS): a scalable
next-gen approach to multilocus, multitaxa phylogenetics. Genome Biol. Evol.
3, 1312–1323. doi: 10.1093/gbe/evr106
Cani, P. D., Osto, M., Geurts, L., and Everard, A. (2012). Involvement of
gut microbiota in the development of low-grade inflammation and type
2 diabetes associated with obesity. Gut Microbes 3, 279–288. doi: 10.4161/gmic.
19625
Caporaso, J. G., Kuczynski, J., Stombaugh, J., Bittinger, K., Bushman, F. D.,
Costello, E. K., et al. (2010). QIIME allows analysis of high-throughput
community sequencing data. Nat. Methods 7, 335–336. doi: 10.1038/
nmeth.f.303
Casey, B. J., Somerville, L. H., Gotlib, I. H., Ayduk, O., Franklin, N. T.,
Askrend, M. K., et al. (2011). Behavioral and neural correlates of delay of
gratification 40 years later. Proc. Natl. Acad. Sci. U S A 108, 14998–15003.
doi: 10.1073/pnas.1108561108
Chyan, Y. J., Poeggeler, B., Omar, R. A., Chain, D. G., Frangione, B., Ghiso, J., et al.
(1999). Potent neuroprotective properties against the Alzheimer β-amyloid by
an endogenous melatonin-related indole structure, indole-3-propionic acid.
J. Biol. Chem. 274, 21937–21942. doi: 10.1074/jbc.274.31.21937
Cirrito, J. R., Deane, R., Fagan, A. M., Spinner, M. L., Parsadanian, M., Finn, M. B.,
et al. (2005). P-glycoprotein deficiency at the blood-brain barrier increases
amyloid-β deposition in an Alzheimer disease mouse model. J. Clin. Invest. 115,
3285–3290. doi: 10.1172/jci25247
Claesson, M. J., Cusack, S., O’sullivan, O., Greene-Diniz, R., De Weerd, H.,
Flannery, E., et al. (2011). Composition, variability, and temporal stability of the
intestinal microbiota of the elderly. Proc. Natl. Acad. Sci. U S A 108, 4586–4591.
doi: 10.1073/pnas.1000097107
Curi, R., de Siqueira Mendes, R., de Campos Crispin, L. A., Norata, G. D.,
Sampaio, S. C., and Newsholme, P. (2017). A past and present overview
of macrophage metabolism and functional outcomes. Clin. Sci. (Lond) 131,
1329–1342. doi: 10.1042/cs20170220
Dehaven, C. D., Evans, A. M., Dai, H., and Lawton, K. A. (2010). Organization of
GC/MS and LC/MS metabolomics data into chemical libraries. J. Cheminform.
2:9. doi: 10.1186/1758-2946-2-9
de la Monte, S. M., and Wands, J. R. (2008). Alzheimer’s disease is
type 3 diabetes-evidence reviewed. J. Diabetes Sci. Technol. 2, 1101–1113.
doi: 10.1177/193229680800200619
Dinan, T. G., and Cryan, J. F. (2013). Melancholic microbes: a link between
gut microbiota and depression? Neurogastroenterol. Motil. 25, 713–719.
doi: 10.1111/nmo.12198
Dou, L., Jourde-Chiche, N., Faure, V., Cerini, C., Berland, Y., Dignat-George, F.,
et al. (2007). The uremic solute indoxyl sulfate induces oxidative stress in
endothelial cells. J. Thromb. Haemost. 5, 1302–1308. doi: 10.1111/j.1538-7836.
2007.02540.x
Ebmeier, K. P., Cavanagh, J. T., Moffoot, A. P., Glabus, M. F., O’carroll, R. E., and
Goodwin, G. M. (1997). Cerebral perfusion correlates of depressed mood. Br.
J. Psychiatry 170, 77–81. doi: 10.1192/bjp.170.1.77
Edgar, R. C. (2010). Search and clustering orders of magnitude faster than BLAST.
Bioinformatics 26, 2460–2461. doi: 10.1093/bioinformatics/btq461
Erickson, M. A., and Banks, W. A. (2013). Blood-brain barrier dysfunction as a
cause and consequence of Alzheimer’s disease. J. Cereb. Blood Flow Metab. 33,
1500–1513. doi: 10.1038/jcbfm.2013.135
Evans, A. M., DeHaven, C. D., Barrett, T., Mitchell, M., and Milgram, E.
(2009). Integrated, nontargeted ultrahigh performance liquid
chromatography/electrospray ionization tandem mass spectrometry
platform for the identification and relative quantification of the small-
molecule complement of biological systems. Anal. Chem. 81, 6656–6667.
doi: 10.1021/ac901536h
Everson-Rose, S. A., and Ryan, J. P. (2015). Diabetes, obesity, and the brain:
new developments in biobehavioral medicine. Psychosom. Med. 77, 612–615.
doi: 10.1097/psy.0000000000000223
Ferretti, L., McCurry, S. M., Logsdon, R., Gibbons, L., and Teri, L. (2001).
Anxiety and Alzheimer’s disease. J. Geriatr. Psychiatry Neurol. 14, 52–58.
doi: 10.1177/089198870101400111
Foster, J. A. (2016). Gut microbiome and behavior: focus on neuroimmune
interactions. Int. Rev. Neurobiol. 131, 49–65. doi: 10.1016/bs.irn.2016.07.005
Foster, J. A., and McVey Neufeld, K. A. (2013). Gut-brain axis: how the
microbiome influences anxiety and depression. Trends Neurosci. 36, 305–312.
doi: 10.1016/j.tins.2013.01.005
Fung, T. C., Olson, C. A., and Hsiao, E. Y. (2017). Interactions between the
microbiota, immune and nervous systems in health and disease. Nat. Neurosci.
20, 145–155. doi: 10.1038/nn.4476
Gallant, M., Rak, M., Szeghalmi, A., Del Bigio, M. R., Westaway, D., Yang, J., et al.
(2006). Focally elevated creatine detected in amyloid precursor protein (APP)
transgenic mice and Alzheimer disease brain tissue. J. Biol. Chem. 281, 5–8.
doi: 10.1074/jbc.c500244200
García-Calatayud, S., Redondo, C., Martín, E., Ruiz, J. I., García-Fuentes, M., and
Sanjurjo, P. (2005). Brain docosahexaenoic acid status and learning in young
rats submitted to dietary long-chain polyunsaturated fatty acid deficiency and
supplementation limited to lactation. Pediatr. Res. 57, 719–723. doi: 10.1203/01.
pdr.0000156506.03057.ad
Geddes, J. W., Panchalingam, K., Keller, J. N., and Pettegrew, J. W. (1997). Elevated
phosphocholine and phosphatidylcholine following rat entorhinal cortex
lesions. Neurobiol. Aging 18, 305–308. doi: 10.1016/s0197-4580(97)80312-0
Goehler, L. E., Park, S. M., Opitz, N., Lyte, M., and Gaykema, R. P.
(2008). Campylobacter jejuni infection increases anxiety-like behavior in the
holeboard: possible anatomical substrates for viscerosensory modulation of
exploratory behavior. Brain Behav. Immun. 22, 354–366. doi: 10.1016/j.bbi.
2007.08.009
Green, S. J., Venkatramanan, R., and Naqib, A. (2015). Deconstructing the
polymerase chain reaction: understanding and correcting bias associated with
primer degeneracies and primer-template mismatches. PLoS One 10:e0128122.
doi: 10.1371/journal.pone.0128122
Guo, J., Bakshi, V., and Lin, A. L. (2015). Early shifts of brain metabolism by
caloric restriction preserve white matter integrity and long-term memory in
aging mice. Front. Aging Neurosci. 7:213. doi: 10.3389/fnagi.2015.00213
Gur, R. C., Gur, R. E., Resnick, S. M., Skolnick, B. E., Alavi, A., and Reivich, M.
(1987). The effect of anxiety on cortical cerebral blood flow and metabolism.
J. Cereb. Blood Flow Metab. 7, 173–177. doi: 10.1038/jcbfm.1987.40
Hadley, W. (2016). ggplot2: Elegant Graphics for Data Analysis. 2nd Edn. Houston,
TX: Springer.
Hamilton, L. K., Dufresne, M., Joppé, S. E., Petryszyn, S., Aumont, A., Calon, F.,
et al. (2015). Aberrant lipid metabolism in the forebrain niche suppresses adult
neural stem cell proliferation in an animal model of Alzheimer’s disease. Cell
Stem Cell 17, 397–411. doi: 10.1016/j.stem.2015.08.001
Harris, K., Kassis, A., Major, G., and Chou, C. J. (2012). Is the gut microbiota a new
factor contributing to obesity and its metabolic disorders? J. Obes. 2012:879151.
doi: 10.1155/2012/879151
Hartz, A. M., Bauer, B., Soldner, E. L., Wolf, A., Boy, S., Backhaus, R., et al.
(2012). Amyloid-β contributes to blood-brain barrier leakage in transgenic
human amyloid precursor protein mice and in humans with cerebral amyloid
angiopathy. Stroke 43, 514–523. doi: 10.1161/strokeaha.111.627562
Hartz, A. M., Miller, D. S., and Bauer, B. (2010). Restoring blood-brain barrier
P-glycoprotein reduces brain amyloid-beta in a mouse model of Alzheimer’s
disease. Mol. Pharmacol. 77, 715–723. doi: 10.1124/mol.109.061754
Hartz, A. M., Zhong, Y., Wolf, A., Levine, H. III., Miller, D. S., and Bauer, B. (2016).
Aβ40 reduces P-glycoprotein at the blood-brain barrier through the ubiquitin-
proteasome pathway. J. Neurosci. 36, 1930–1941. doi: 10.1523/jneurosci.0350-
15.2016
Hill, J. M., Clement, C., Pogue, A. I., Bhattacharjee, S., Zhao, Y., and Lukiw, W. J.
(2014). Pathogenic microbes, the microbiome, and Alzheimer’s disease (AD).
Front. Aging Neurosci. 6:127. doi: 10.3389/fnagi.2014.00127
Hong, X., To, X. V., Teh, I., Soh, J. R., and Chuang, K. H. (2015). Evaluation of
EPI distortion correction methods for quantitative MRI of the brain at high
magnetic field. Magn. Reson. Imaging 33, 1098–1105. doi: 10.1016/j.mri.2015.
06.010
Hu, X., Wang, T., and Jin, F. (2016). Alzheimer’s disease and gut microbiota. Sci.
China Life Sci. 59, 1006–1023. doi: 10.1007/s11427-016-5083-9
Huuskonen, J., Suuronen, T., Nuutinen, T., Kyrylenko, S., and Salminen, A.
(2004). Regulation of microglial inflammatory response by sodium butyrate
and short-chain fatty acids. Br. J. Pharmacol. 141, 874–880. doi: 10.1038/sj.bjp.
0705682
Frontiers in Aging Neuroscience | www.frontiersin.org 12 September 2017 | Volume 9 | Article 298
Hoffman et al. Age Effects on Brain and Gut
Ihaka, R., and Gentleman, R. (1996). R: a language for data analysis and graphics.
J. Comput. Graph. Stat. 5, 299–314. doi: 10.1080/10618600.1996.10474713
Ivanisevic, J., Stauch, K. L., Petrascheck, M., Benton, H. P., Epstein, A. A.,
Fang, M., et al. (2016). Metabolic drift in the aging brain. Aging (Albany NY) 8,
1000–1020. doi: 10.18632/aging.100961
Jaeschke, H. (2011). Reactive oxygen and mechanisms of inflammatory liver
injury: present concepts. J. Gastroenterol. Hepatol. 26, 173–179. doi: 10.1111/j.
1440-1746.2010.06592.x
Kau, A. L., Ahern, P. P., Griffin, N. W., Goodman, A. L., and Gordon, J. I. (2011).
Human nutrition, the gut microbiome and the immune system. Nature 474,
327–336. doi: 10.1038/nature10213
Keegan, M. R., Chittiprol, S., Letendre, S. L., Winston, A., Fuchs, D., Boasso, A.,
et al. (2016). Tryptophan metabolism and its relationship with depression and
cognitive impairment among HIV-infected individuals. Int. J. Tryptophan. Res.
9, 79–88. doi: 10.4137/ijtr.s36464
Kozieł, R., Ruckenstuhl, C., Albertini, E., Neuhaus, M., Netzberger, C., Bust, M.,
et al. (2014). Methionine restriction slows down senescence in human diploid
fibroblasts. Aging Cell 13, 1038–1048. doi: 10.1111/acel.12266
Langille, M. G., Meehan, C. J., Koenig, J. E., Dhanani, A. S., Rose, R. A.,
Howlett, S. E., et al. (2014). Microbial shifts in the aging mouse gut. Microbiome
2:50. doi: 10.1186/s40168-014-0050-9
Laukens, D., Brinkman, B. M., Raes, J., De Vos, M., and Vandenabeele, P.
(2016). Heterogeneity of the gut microbiome in mice: guidelines for
optimizing experimental design. FEMS Microbiol. Rev. 40, 117–132.
doi: 10.1093/femsre/fuv036
Lin, A. L., Coman, D., Jiang, L., Rothman, D. L., and Hyder, F. (2014). Caloric
restriction impedes age-related decline of mitochondrial function and neuronal
activity. J. Cereb. Blood Flow Metab. 34, 1440–1443. doi: 10.1038/jcbfm.
2014.114
Lin, A. L., Jahrling, J. B., Zhang, W., DeRosa, N., Bakshi, V., Romero, P.,
et al. (2017). Rapamycin rescues vascular, metabolic and learning deficits in
apolipoprotein E4 transgenic mice with pre-symptomatic Alzheimer’s disease.
J. Cereb. Blood Flow Metab. 37, 217–226. doi: 10.1177/0271678x15621575
Lin, A. L., Pulliam, D. A., Deepa, S. S., Halloran, J. J., Hussong, S. A.,
Burbank, R. R., et al. (2013). Decreased in vitro mitochondrial function is
associated with enhanced brain metabolism, blood flow and memory in Surf1-
deficient mice. J. Cereb. Blood Flow Metab. 33, 1605–1611. doi: 10.1038/jcbfm.
2013.116
Lin, A. L., Zhang, W., Gao, X., and Watts, L. (2015). Caloric restriction
increases ketone bodies metabolism and preserves blood flow in aging
brain. Neurobiol. Aging 36, 2296–2303. doi: 10.1016/j.neurobiolaging.
2015.03.012
Lütjohann, D., Papassotiropoulos, A., Björkhem, I., Locatelli, S., Bagli, M.,
Oehring, R. D., et al. (2000). Plasma 24S-hydroxycholesterol (cerebrosterol)
is increased in Alzheimer and vascular demented patients. J. Lipid Res. 41,
195–198.
Lynch, A. M., Murphy, K. J., Deighan, B. F., O’Reilly, J.-A., Gun’ko, Y. K.,
Cowley, T. R., et al. (2010). The impact of glial activation in the aging brain.
Aging Dis. 1, 262–278.
Lyte, M., Li, W., Opitz, N., Gaykema, R. P., and Goehler, L. E. (2006). Induction
of anxiety-like behavior in mice during the initial stages of infection with the
agent of murine colonic hyperplasia citrobacter rodentium. Physiol. Behav. 89,
350–357. doi: 10.1016/j.physbeh.2006.06.019
Lyte, M., Varcoe, J. J., and Bailey, M. T. (1998). Anxiogenic effect of subclinical
bacterial infection in mice in the absence of overt immune activation. Physiol.
Behav. 65, 63–68. doi: 10.1016/s0031-9384(98)00145-0
Martínez-del Campo, A., Bodea, S., Hamer, H. A., Marks, J. A., Haiser, H. J.,
Turnbaugh, P. J., et al. (2015). Characterization and detection of
a widely distributed gene cluster that predicts anaerobic choline
utilization by human gut bacteria. MBio 6:e00042-15. doi: 10.1128/mbio.
00042-15
McDonald, D., Price, M. N., Goodrich, J., Nawrocki, E. P., DeSantis, T. Z.,
Probst, A., et al. (2012). An improved greengenes taxonomy with explicit ranks
for ecological and evolutionary analyses of bacteria and archaea. ISME J. 6,
610–618. doi: 10.1038/ismej.2011.139
Melamed, E., Lavy, S., Bentin, S., Cooper, G., and Rinot, Y. (1980). Reduction in
regional cerebral blood flow during normal aging in man. Stroke 11, 31–35.
doi: 10.1161/01.str.11.1.31
Miller, D. S., Bauer, B., and Hartz, A. M. (2008). Modulation of P-glycoprotein
at the blood-brain barrier: opportunities to improve central nervous system
pharmacotherapy. Pharmacol. Rev. 60, 196–209. doi: 10.1124/pr.107.07109
Montine, T. J., Milatovic, D., Gupta, R. C., Valyi-Nagy, T., Morrow, J. D.,
and Breyer, R. M. (2002). Neuronal oxidative damage from activated
innate immunity is EP2 receptor-dependent. J. Neurochem. 83, 463–470.
doi: 10.1046/j.1471-4159.2002.01157.x
Morrison, L. D., and Kish, S. J. (1995). Brain polyamine levels are altered
in Alzheimer’s disease. Neurosci. Lett. 197, 5–8. doi: 10.1016/0304-
3940(95)11881-v
Ohta, T., Masutomi, N., Tsutsui, N., Sakairi, T., Mitchell, M., Milburn, M. V., et al.
(2009). Untargeted metabolomic profiling as an evaluative tool of fenofibrate-
induced toxicology in Fischer 344 male rats. Toxicol. Pathol. 37, 521–535.
doi: 10.1177/0192623309336152
Oksanen, J., Kindt, R., Legendre, P., O’Hara, B., Stevens, M. H. H.,
Oksanen, M. J., et al. (2007). vegan: Community Ecology Package. R package
version 1.8-8. Available online at: http://cran.r-project.org/, http://r-forge.r-
project.org/projects/vegan/
O’Neill, L. A., Kishton, R. J., and Rathmell, J. (2016). A guide to
immunometabolism for immunologists. Nat. Rev. Immunol. 16, 553–565.
doi: 10.1038/nri.2016.70
Palermo, L., Geberhiwot, T., MacDonald, A., Limback, E., Hall, S. K.,
and Romani, C. (2017). Cognitive outcomes in early-treated adults
with phenylketonuria (PKU): a comprehensive picture across domains.
Neuropsychology 31, 255–267. doi: 10.1037/neu0000337
Pamplona, R., and Barja, G. (2006). Mitochondrial oxidative stress, aging and
caloric restriction: the protein and methionine connection. Biochim. Biophys.
Acta 1757, 496–508. doi: 10.1016/j.bbabio.2006.01.009
Parikh, I., Guo, J., Chuang, K. H., Zhong, Y., Rempe, R. G., Hoffman, J. D., et al.
(2016). Caloric restriction preserves memory and reduces anxiety of aging
mice with early enhancement of neurovascular functions. Aging (Albany NY)
8, 2814–2826. doi: 10.18632/aging.101094
Park, J., and Moghaddam, B. (2017). Impact of anxiety on prefrontal cortex
encoding of cognitive flexibility. Neuroscience 345, 193–202. doi: 10.1016/j.
neuroscience.2016.06.013
Parnetti, L., Mignini, F., Tomassoni, D., Traini, E., and Amenta, F. (2007).
Cholinergic precursors in the treatment of cognitive impairment of vascular
origin: ineffective approaches or need for re-evaluation? J. Neurol. Sci. 257,
264–269. doi: 10.1016/j.jns.2007.01.043
Petit-Taboué, M. C., Landeau, B., Desson, J. F., Desgranges, B., and Baron, J. C.
(1998). Effects of healthy aging on the regional cerebral metabolic rate of
glucose assessed with statistical parametric mapping. Neuroimage 7, 176–184.
doi: 10.1006/nimg.1997.0318
Rao, A. V., Bested, A. C., Beaulne, T. M., Katzman, M. A., Iorio, C., Berardi, J. M.,
et al. (2009). A randomized, double-blind, placebo-controlled pilot study of a
probiotic in emotional symptoms of chronic fatigue syndrome. Gut Pathog. 1:6.
doi: 10.1186/1757-4749-1-6
Reiman, E. M., Chen, K., Alexander, G. E., Caselli, R. J., Bandy, D., Osborne, D.,
et al. (2004). Functional brain abnormalities in young adults at genetic risk for
late-onset Alzheimer’s dementia. Proc. Natl. Acad. Sci. U S A 101, 284–289.
doi: 10.1073/pnas.2635903100
Reitz, C., Brayne, C., and Mayeux, R. (2011). Epidemiology of Alzheimer disease.
Nat. Rev. Neurol. 7, 137–152. doi: 10.1038/nrneurol.2011.2
Ricciotti, E., and Fitzgerald, G. A. (2011). Prostaglandins and inflammation.
Arterioscler. Thromb. Vasc. Biol. 31, 986–1000. doi: 10.1161/ATVBAHA.110.
207449
Ron-Harel, N., Santos, D., Ghergurovich, J. M., Sage, P. T., Reddy, A.,
Lovitch, S. B., et al. (2016). Mitochondrial biogenesis and proteome remodeling
promote one-carbon metabolism for T cell activation. Cell Metab. 24, 104–117.
doi: 10.1016/j.cmet.2016.06.007
Schnorr, S. L., and Bachner, H. A. (2016). Integrative therapies in anxiety
treatment with special emphasis on the gut microbiome. Yale J. Biol. Med. 89,
397–422.
Schweinberger, B. M., and Wyse, A. T. (2016). Mechanistic basis of
hypermethioninemia. Amino Acids 48, 2479–2489. doi: 10.1007/s00726-
016-2302-4
Sha, W., da Costa, K. A., Fischer, L. M., Milburn, M. V., Lawton, K. A., Berger, A.,
et al. (2010). Metabolomic profiling can predict which humans will develop
Frontiers in Aging Neuroscience | www.frontiersin.org 13 September 2017 | Volume 9 | Article 298
Hoffman et al. Age Effects on Brain and Gut
liver dysfunction when deprived of dietary choline. FASEB J. 24, 2962–2975.
doi: 10.1096/fj.09-154054
Sharon, G., Sampson, T. R., Geschwind, D. H., and Mazmanian, S. K. (2016).
The central nervous system and the gut microbiome. Cell 167, 915–932.
doi: 10.1016/j.cell.2016.10.027
Sievert, C., Parmer, C., Hocking, T., Chamberlain, S., Ram, K., Corvellec, M.,
et al. (2016). plotly: Create Interactive Web Graphics via Plotly’s
JavaScript Graphing Library. Available online at: https://cran.r-
project.org/web/packages/plotly/index.html
Sood, A., Warren Beach, J., Webster, S. J., Terry, A. V., and Buccafusco, J. J. (2007).
The effects of JWB1–84-1 on memory-related task performance by amyloid
Aβ transgenic mice and by young and aged monkeys. Neuropharmacology 53,
588–600. doi: 10.1016/j.neuropharm.2007.06.028
Sudo, N., Chida, Y., Aiba, Y., Sonoda, J., Oyama, N., Yu, X. N., et al.
(2004). Postnatal microbial colonization programs the hypothalamic-pituitary-
adrenal system for stress response in mice. J. Physiol. 558, 263–275.
doi: 10.1113/jphysiol.2004.063388
Tremlett, H., Bauer, K. C., Appel-Cresswell, S., Finlay, B. B., and Waubant, E.
(2017). The gut microbiome in human neurological disease: a review. Ann.
Neurol. 81, 369–382. doi: 10.1002/ana.24901
Turnbaugh, P. J., Ley, R. E., Mahowald, M. A., Magrini, V., Mardis, E. R.,
and Gordon, J. I. (2006). An obesity-associated gut microbiome with
increased capacity for energy harvest. Nature 444, 1027–1031. doi: 10.1038/
nature05414
Vagelatos, N. T., and Eslick, G. D. (2013). Type 2 diabetes as a risk
factor for Alzheimer’s disease: the confounders, interactions and
neuropathology associated with this relationship. Epidemiol. Rev. 35, 152–160.
doi: 10.1093/epirev/mxs012
Verbeke, K. A., Boesmans, L., and Boets, E. (2014). Modulating the microbiota in
inflammatory bowel diseases: prebiotics, probiotics or faecal transplantation?
Proc. Nutr. Soc. 73, 490–497. doi: 10.1017/s0029665114000639
Verdam, F. J., Fuentes, S., de Jonge, C., Zoetendal, E. G., Erbil, R., Greve, J. W.,
et al. (2013). Human intestinal microbiota composition is associated with local
and systemic inflammation in obesity. Obesity (Silver Spring) 21, E607–E615.
doi: 10.1002/oby.20466
Wallace, D. C. (2011). Bioenergetic origins of complexity and disease. Cold Spring
Harb. Symp. Quant. Biol. 76, 1–16. doi: 10.1101/sqb.2011.76.010462
Walters, W., Hyde, E. R., Berg-Lyons, D., Ackermann, G., Humphrey, G.,
Parada, A., et al. (2015). Improved bacterial 16S rRNA gene (V4 and V4–5)
and fungal internal transcribed spacer marker gene primers for microbial
community surveys. mSystems 1:e00009-15. doi: 10.1128/mSystems.00009-15
Walters, W. A., Xu, Z., and Knight, R. (2014). Meta-analyses of human gut
microbes associated with obesity and IBD. FEBS Lett. 588, 4223–4233.
doi: 10.1016/j.febslet.2014.09.039
Wang, Z., Klipfell, E., Bennett, B. J., Koeth, R., Levison, B. S., Dugar, B., et al.
(2011). Gut flora metabolism of phosphatidylcholine promotes cardiovascular
disease. Nature 472, 57–63. doi: 10.1038/nature09922
Wang, Z., Tang, W. H., Buffa, J. A., Fu, X., Britt, E. B., Koeth, R. A., et al. (2014).
Prognostic value of choline and betaine depends on intestinal microbiota-
generated metabolite trimethylamine-N-oxide. Eur. Heart J. 35, 904–910.
doi: 10.1093/eurheartj/ehu002
Weber, D., Oefner, P. J., Hiergeist, A., Koestler, J., Gessner, A., Weber, M., et al.
(2015). Low urinary indoxyl sulfate levels early after transplantation reflect
a disrupted microbiome and are associated with poor outcome. Blood 126,
1723–1728. doi: 10.1182/blood-2015-04-638858
Weiner, J. III., Parida, S. K., Maertzdorf, J., Black, G. F., Repsilber, D.,
Telaar, A., et al. (2012). Biomarkers of inflammation, immunosuppression
and stress with active disease are revealed by metabolomic profiling
of tuberculosis patients. PLoS One 7:e40221. doi: 10.1371/journal.pone.
0040221
Wissmann, P., Geisler, S., Leblhuber, F., and Fuchs, D. (2013). Immune
activation in patients with Alzheimer’s disease is associated with high serum
phenylalanine concentrations. J. Neurol. Sci. 329, 29–33. doi: 10.1016/j.jns.
2013.03.007
Wong, M. L., Rettori, V., al-Shekhlee, A., Bongiorno, P. B., Canteros, G.,
Mccann, S. M., et al. (1996). Inducible nitric oxide synthase gene
expression in the brain during systemic inflammation. Nat. Med. 2, 581–584.
doi: 10.1038/nm0596-581
Wyss-Coray, T., and Rogers, J. (2012). Inflammation in Alzheimer
disease-a brief review of the basic science and clinical literature.
Cold Spring Harb. Perspect. Med. 2:a006346. doi: 10.1101/cshperspect.
a006346
Xia, S., Zhang, X., Zheng, S., Khanabdali, R., Kalionis, B., Wu, J., et al. (2016). An
update on inflamm-aging: mechanisms, prevention and treatment. J. Immunol.
Res. 2016:8426874. doi: 10.1155/2016/8426874
Zgoda-Pols, J. R., Chowdhury, S., Wirth, M., Milburn, M. V., Alexander, D. C.,
and Alton, K. B. (2011). Metabolomics analysis reveals elevation of
3-indoxyl sulfate in plasma and brain during chemically-induced
acute kidney injury in mice: investigation of nicotinic acid receptor
agonists. Toxicol. Appl. Pharmacol. 255, 48–56. doi: 10.1016/j.taap.
2011.05.015
Zhang, L. S., and Davies, S. S. (2016). Microbial metabolism of dietary components
to bioactive metabolites: opportunities for new therapeutic interventions.
Genome Med. 8:46. doi: 10.1186/s13073-016-0296-x
Zhang, J., Kobert, K., Flouri, T., and Stamatakis, A. (2014). PEAR: a fast
and accurate illumina paired-end reAd mergeR. Bioinformatics 30, 614–620.
doi: 10.1093/bioinformatics/btt593
Zlokovic, B. V. (2011). Neurovascular pathways to neurodegeneration in
Alzheimer’s disease and other disorders. Nat. Rev. Neurosci. 12, 723–738.
doi: 10.1038/nrn3114
Conflict of Interest Statement: The authors declare that the research was
conducted in the absence of any commercial or financial relationships that could
be construed as a potential conflict of interest.
Copyright © 2017 Hoffman, Parikh, Green, Chlipala, Mohney, Keaton, Bauer, Hartz
and Lin. This is an open-access article distributed under the terms of the Creative
Commons Attribution License (CC BY). The use, distribution or reproduction in
other forums is permitted, provided the original author(s) or licensor are credited
and that the original publication in this journal is cited, in accordance with accepted
academic practice. No use, distribution or reproduction is permitted which does not
comply with these terms.
Frontiers in Aging Neuroscience | www.frontiersin.org 14 September 2017 | Volume 9 | Article 298
